About: http://data.cimple.eu/news-article/1dd3c6e204c562f6dc0eabca898a7a28fa0f0bd20402f5cd09f67569

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/1dd3c6e204c562f6dc0eabca898a7a28fa0f0bd20402f5cd09f67569 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The United States on Tuesday authorized its first rapid at-home test for Covid-19, which is available over-the-counter and produces a result in around 20 minutes. The test, made by California-based Ellume, will sell for around $30 and the company plans to roll out three million units in January 2021, and millions more in subsequent months. Stephen Hahn, commissioner of the Food and Drug Administration, said the emergency use authorization represented a "major milestone." "We are helping expand Americans' access to testing, reducing the burden on laboratories and test supplies, and giving Americans more testing options from the comfort and safety of their own homes," he said. It is an "antigen" test, meaning it works by detecting a surface molecule of the coronavirus, unlike the more common PCR tests that look for the virus' genetic material. The technology involved is similar to a home pregnancy test. The Ellume test uses a nasal swab that doesn't go as far back as the nasopharyngeal swabs used in clinical settings, and is therefore more comfortable to self-administer. The sample is then inserted into a single-use cartridge. According to the FDA, it correctly identified 96 percent of positive samples and 100 percent of negative samples in individuals with symptoms. In people without symptoms, the test correctly identified 91 percent of positive samples and 96 percent of negative samples. The FDA said that for patients without symptoms, "positive results should be treated as presumptively positive until confirmed by another test as soon as possible." It added that individuals with positive results should self-isolate and seek additional care from their health care provider, while people who test negative but experience Covid symptoms should also seek follow up with their health care provider. The home test connects with an app on the user's smartphone to interpret the results. Results take as little as 20 minutes and are delivered via the app, which requires users to input their zip code and date of birth, to report to public health authorities. Providing the name and email address is optional. Ellume developed the test with $30 million in government funding from the National Institutes of Health. ia/st
schema:headline	US authorizes first at-home Covid test, results in 20 minutes
schema:mentions	Health professional Pharynx ZIP Code Molecule ROM cartridge Over-the-counter drug Antigen Pregnancy test Smartphone Public health Ia (cuneiform) Food and Drug Administration Polymerase chain reaction Virus Coronavirus disease United States Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-12-15 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	79 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software